DC 101
Alternative Names: anti-flk-1 monoclonal antibody; DC101Latest Information Update: 23 Mar 2009
Price :
$50 *
At a glance
- Originator ImClone Systems
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Angiogenesis inhibitors; Antibody-dependent cell cytotoxicity; Immunostimulants; Intercellular signalling peptide and protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 23 Mar 2009 Discontinued - Preclinical for Cancer in USA (Injection)
- 24 Nov 2008 ImClone Systems has been acquired by Eli Lilly
- 24 Oct 2008 Pharmacodynamics data from a preclinical trial in Cancer presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (EORTC-NCI-AACR-2008)